Video
Video : The SHM Research Committee: Expanding the role and footprint of research in hospital medicine
April 9, 2018
ORLANDO – In a video interview, Stephanie Mueller, MD, SFHM, discusses the scope and importance of the SHM Research Committee.
News
SHM presidents: Innovate and avoid complacency
April 9, 2018
ORLANDO — The Society of Hospital Medicine’s immediate past president and current president opened the SHM annual meeting with a call to innovate.
News
Hospitalists ‘perfectly poised’ to drive health care reform
April 9, 2018
ORLANDO — HM18 keynote speaker Kate Goodrich, MD, said hospitalists are well positioned to help drive important change to the U.S. health care system.
Video
Video: SHM President Nasim Afsar seeks an “unrelenting focus on delivering value”
April 8, 2018
ORLANDO – New SHM President Nasim Afsar talks about her goals for the future of hospital medicine.
News
Two scoring systems helpful in diagnosing heparin-induced thrombocytopenia
April 8, 2018
SAN DIEGO – Both the 4Ts Score or the HIT Expert Probability (HEP) Score performed well in a real-world study.
News
Boosting bedside skills in hands-on session
April 8, 2018
‘Interactive focus’ distinguishes training.
News
Practical changes for improving practice management
April 8, 2018
“We can’t effectively use the same approaches that other medical specialties use to ensure we have successful practices.”
News
Few acutely ill hospitalized patients receive VTE prophylaxis
April 2, 2018
The results “imply that there is a significantly unmet need for effective VTE prophylaxis in both the inpatient and outpatient continuum of care.”
News
Protocol helped identify hospitalized children at risk for VTE
March 30, 2018
SAN DIEGO – Children with hospital-acquired VTE tended to be more medically complex, a single-center study showed.
News
Warfarin dose capping avoided supratherapeutic INRs in hospitalized elderly
March 30, 2018
SAN DIEGO – Limiting the initial dose of warfarin to 2.5 mg or less for hospitalized patients aged 85 years and older led to significant reductions in supratherapeutic INRs.